Datum objave: 01.06.2011
Kategorija: Aktualno na Univerzi
Allinky Biopharma
Contact Person
VEGA, MIguel (Mr.)
Allinky Biopharma
Contact
Telephone: +34-620-947503 +34-620-947503
Collaboration
Project Proposal
Title: Targeting molecular pathophysiology of type II diabetes: preclinical development and safety evaluation of allosteric MAP Kinase modulators to decrease insulin resistance (GLYKONTROL)
Type Details: HEALTH.2012.2.4.3-1
Targeting molecular pathophysiology of type II diabetes: preclinical development and safety evaluation of allosteric MAP Kinase modulators to decrease insulin resistance (GLYKONTROL)
Programme (Collaboration EU R&D): FP7-HEALTH
Expiry Date: 2012-05-26
Target Partner
Organisation Details
Allinky BiopharmaName: Allinky Biopharma
Region: COMUNIDAD DE MADRID
SPAIN
Type: SME (Small or Medium sized Enterprise)
Number of Employees: < 10
RCN: 87122
Quality Validation Date: 2011-05-26
Update Date: 2011-05-27